Skip to main content

Prevalence of vitamin D deficiency and consequences for PTH reference values.

Deckers MM, de Jongh RT, Lips PT, Penninx BW, Milaneschi Y, Smit JH, van Schoor NM, Blankenstein MA, Heijboer AC

Publication: Clin Chim Acta (2013) • Vol 426 • Page 41-5PMID: 24012652View on PubMed

Purpose

The purpose of this paper was to determine the effects of 25-hydroxyvitamin D (25OHD) levels on parathyroid hormone (PTH) levels in EDTA plasma.

Conclusion

EDTA plasma PTH reference values were lower when serum 25OHD levels were 50 nmol/L or greater than when they were lower than 50 nmol/L.

Studies (1)

Purpose

The purpose of this study was to determine the effects of serum 25OHD levels and other preacquisition variables on PTH levels in EDTA plasma from the Longitudinal Aging Study Amsterdam (LASA) and the Netherlands Study of Depression and Anxiety (NESDA) cohorts. The specimens from the LASA cohort were obtained in 2002 after patients had a light breakfast and stored at -20 degrees C until analysis in 2009. Specimens from the NESDA cohort were collected after an overnight fast and stored at -80 degrees C from between 2004 and 2007 until analysis in 2011. Each cohort was analyzed separately. 25OHD levels were measured by radioimmunoassay (RIA) among the LASA cohort and by isotope dilution/online solid-phase extraction liquid chromatography/tandem mass spectrometry (ID-XLC-MS/ MS) among the NESDA cohort.

Summary of Findings

For both the LASA and NESDA cohorts, EDTA plasma PTH reference values were lower when serum 25OHD levels were 50 nmol/L or greater than when they were < 50 nmol/L. PTH references values were higher among the specimens from the LASA cohort than the NESDA cohort, but the authors state this was not a factor of different 25OHD assays between the two cohorts. The authors also state that no clinically significant differences in PTH levels were noted based on patient age, gender, or BMI and that neither these nor creatinine levels were confounding variables in the noted relationship between 25OHD and PTH levels.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    PeptideClinical chemistry/auto analyzer
    Small moleculeRadioimmunoassay
    Small moleculeLC-MS or LC-MS/MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    25ODH < 50 nmol/L
    25ODH concentration of 50 nmol/L or greater
    A range of creatinine levels
    PreaquisitionPatient age
    18-65 years (NESDA)
    55-65 years (LASA)
    PreaquisitionPatient body mass index
    16.3-47.3 (NESDA)
    17.9-45 (LASA)
    PreaquisitionPatient gender
    Female
    Male
    StorageStorage duration
    4-7 years
    7 years
    Radioimmunoassay SpecificTechnology platform
    ID-XLC-MS/ MS